We determined the suitability of various heparin salts used for anticoagulation of whole-blood specimens for measurement of ionized calcium (iCa), blood gases, and electrolytes. We were particularly interested in a new heparin product containing both zinc and lithium cations (CNLZ heparin), in which the binding sites with greatest affinity for divalent cations are bound with zinc and lowaffinity sites with lithium. In initial experiments Li heparin decreased iCa concentrations 0.07 mmol/L at the lowest heparin concentration (3000 units/L) and progressively lowered them at higher concentrations. Zn heparin initially increased iCa concentrations 0.06 mmol/L but progressively lowered them as the heparin concentration was increased. Li heparin interfered even when present in amounts (9 units per 3-mL syringe) minimally effective in preventing coagulation. Use of CNLZ heparin (36 units per 3-mL syringe; Zn 63-78 g/kg of heparin) largely eliminated interference of heparin in iCa measurements. In studies that included the effects of concentration of heparm through partial filling of syringes, specimens anticoagulated with CNLZ heparin compared well with unheparinized controls in measurements of iCa, blood gases, and electrolytes. Blood gases and iCa results on CNLZheparinized specimens from intensive-care-unit patients also compared well with specimens anticoagulated with a preparation of heparin (EB heparin) in which calcium has been added to balance the calcium-binding capacity. However, the presence of calcium in EB heparin significantly increased measured total calcium concentrations, whereas the new CNLZ heparin did not interfere in total calcium determinations. by (a) reducing the heparin content of the syringe to the absolute minimum necessary for anticoagulation (6); (b) using the zinc salt of heparin (7); and (c) titrating the heparin with calcium to "balance" the heparin binding effect (8, 9).
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Measurement of ionized calcium (iCa) is increasingly used in instances
where total calcium measurements provide an incomplete assessment of physiologic calcium status (1), e.g., in premature infants (2) or those with derangement of plasma protein metabolism ( 
3)6
Continuing improvement in analytical technology has made iCa analysis more reliable and practical for the clinical laboratory (4) . One aspect of this improved technology is that small amounts of whole blood can be used as specimen, obviating the need for separation of plasma and facilitating anaerobic handling.
Change in specimen pH during transport/processing/analysis, resulting from the evolution of C02, significantly decreases iCa (2). Whole-blood specimens for iCa analyses are usually collected in syringes containing heparin, and many hospitals have found it efficient to collect and perform iCa, arterial blood gas, and other electrolyte analyses on the same specimen. by (a) reducing the heparin content of the syringe to the absolute minimum necessary for anticoagulation (6) ; (b) using the zinc salt of heparin (7); and (c) titrating the heparin with calcium to "balance" the heparin binding effect (8, 9).
Heparin binding of divalent cations is heterogeneous, reflecting the presence of both high-and low-affinity binding sites (10). Recently, an alternative heparin product, calcium-neutralized lithium zinc heparmn (CNLZ heparin), that took into account this heterogeneity was developed:
The lithium salt of heparin was treated with sufficient zinc to occupy high-affinity sites, and the lower-affinity binding sites were exchanged back to lithium. The rationale is that calcium binding to heparin occurs at sites with high affinity for divalent ions, and that titration with zinc would preferentially occupy these sites with a nondissociable metal ion. Subsequent exposure of blood specimens to the titrated heparm would not alter iCa concentrations because binding of calcium to heparmn would be prevented by occupation of the high-affinity binding sites by zinc. Here we report studies of the optimization of zinc content and a clinical laboratory evaluation of the efficacy of CNLZ heparin. Blood (10-20 mL) was drawn and discarded to minimize the effects of the temporary stasis needed to achieve venipuncture, and then blood was drawn in various volumes into 3.0-mL plain syringes that either contained dry heparmn or had 12 tL of various heparin solutions pipetted into the syringe tip dead space with a fine-tip variable-volume pipette. A syringe without anticoagulant, which served as the control, was always drawn last and analyzed immediately (<5 mm), before clot formation occurred (9) .
For evaluation of the 3-mL syringe containing 36 units of lyophilized CNLZ heparin under anticipated clinical conditions, specimens (2-3 mL) were drawn from patients in a cardiac intensive-care unit through arterial lines surgically placed in the radial artery. Three specimens were collected from each patient with a 3-mL syringe containing 36 units of lyophilized CNLZ heparin, a 3-mL syringe containing 120 units of lyophiized EB heparin, and a plain syringe. (Fig. 1) . The decreases in iCa 
EB heparin did not alter iCa concentrations in any of the specimens collected over the full range of heparin concentrations (Fig. 1) . We also observed that Zn heparin lowered the pH of whole-blood specimens from a mean of 7.39 (± 0.03; n = 4) in the controls to 7.38 (± 0.02) in specimens collected with the lowest concentration (33 000 unitslL) of Zn heparin, and pH fell progressively to 7.28 in specimens collected with 248 000 units/L Zn heparin. All pH measurements of specimens containing Zn heparin except that collected with the lowest concentration were statistically different from the control (P <0.05).
To minimize heparmn interference in iCa measurements, some manufacturers of commercial heparin-contaming syringes reduce the heparin content of their products to the minimum necessary to assure adequate anticoagulation.
When the Zn heparin content of 3-mL syringes was reduced from 100 to 30 units and volunteer specimens were collected in syringe volumes of 3.0-0.4 mL, iCa concentrations were modestly but consistently higher than for nonanticoagulated controls at heparin concentrations of 10 000-40 000 units/L (Fig. 2) . iCa concentrations decreased at higher Zn heparin concentrations; pH was not decreased at any Zn heparmn concentration.
We also examined the efficacy of reducing the Li heparin content of syringes; the first experiment involved 3-mL syringes with 30 units of Li heparin and a second experiment involved syringes with 9 units of Li heparin (Fig. 2) . In both instances, iCa concentrations were only slightly lower than controls at the lowest heparmn concentration, but dropped rapidly and progressively as the heparmn concentration increased (draw volume decreased) (Fig. 2) , despite the minimal amounts of heparmn present. Clotting of specimens was not observed during the period (<1 h) required to complete these analyses.
Because at low heparin concentrations (10 000-50 000 unitslL) the effects of Zn heparin and Li heparin on iCa values appeared to be opposite, we evaluated a series of 12 CNLZ heparin preparations with zinc contents of 19.5-127 g/kg dry porcine heparin. As before, 3-mL syringes containing 36 units of the varied preparations of CNLZ heparin were used to draw blood from volunteers at final syringe volumes of 0.4-3.0 mL. Control specimens were collected in plain syringes without anticoagulant and analyzed promptly. The iCa results are presented as a bias plot, in which the unheparinized (control) iCa value was the starting point for experimental values in a given experiment and subsequent points are expressed as net change from the control value in each experiment (Fig. 3) ; representative curves for six doses are presented. When Zn content exceeded 78 g/kg heparin, modest but sustained increases in iCa concentrations were found at draw volumes of 1.5 mL. Zn content of <59 gfkg resulted in modest but reproducible decreases in iCa concentrations in the range of 12 000-48 000 unitslL heparin of blood gas, total calcium, and iCa in specimens collected from volunteers. Whole-blood specimens collected without anticoagulant and analyzed immediately served as controls, and specimens collected in syringes containing EB heparmn were also drawn for comparison. Blood was drawn into each type of syringe at volumes of 3.0 mL (nominal maximum capacity) and 0.75 mL, regarded as the minimum volume in routine clinical use. Results for iCa in specimens collected in both CNLZ and EB heparin-containing syringes agreed well at both draw volumes with control syringe results ( Table 1) (Table 2) ; all P values were >0.05 and means for each parameter were similar. Total calcium concentrations were also measured in plasma obtained from these specimens because of the potential for EB heparin to artifactually increase this measurement (9). Total calcium values from specimens collected with CNLZ heparin agreed well with paired control results ( Table 2 ). Though total calcium was significantly decreased in the 0.75-mL specimens, the average difference between paired specimens was a clinically insignificant 0.07 mmolfL. Total calcium values for specimens collected with EB heparin were significantly higher (P <0.001) at both 3.0 and 0.75 mL than the control syringe results (Table 2 ). Average differences between paired specimens for total calcium were 0.09 mmol/L higher in 3.0-mL specimens and 0.46 mmol/L higher in 0.75-mL specimens; in the latter, the average total calcium concentration (2.85 mmol/L) exceeded our laboratory normal range (2.2-2.6 mmoIIL).
The efficacy of CNLZ heparin (36 unitsl3-mL syringe, Zn 77.6 g/kg heparin, lyophilized form) was assessed with arterial blood specimens collected from cardiac intensive-care unit patients for iCa, total calcium, electrolytes, and blood gas analyses. A whole-blood specimen was collected in the laboratory's routinely used syringe containing EB heparmn (100 units/3-mL syringe) for In comparisons of blood gas results from CNLZ heparim specimens with results from EB heparin (control) specimens, there were no statistically or clinically significant differences ( Table 4) . Total calcium values were compared for plasma obtained from arterial blood specimens collected with either CNLZ heparmn or EB heparin vs a concomitantly collected serum specimen ( Table 3) 
Discussion
The ideal syringe for collection of specimens for iCa analysis would contain sufficient anticoagulant so that the specimen would remain free of clots for a period that 
